The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 20, 2019

Filed:

Jan. 29, 2016
Applicants:

Nof Corporation, Tokyo, JP;

National University Corporation Hokkaido University, Sapporo-shi, Hokkaido, JP;

Inventors:

Yuta Nakai, Kawasaki, JP;

Kota Tange, Kawasaki, JP;

Hidetaka Akita, Sapporo, JP;

Hideyoshi Harashima, Sapporo, JP;

Ryohei Togashi, Sapporo, JP;

Naoya Miura, Sapporo, JP;

Mio Maeta, Sapporo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 295/088 (2006.01); A61K 45/00 (2006.01); A61K 47/22 (2006.01); A61K 9/127 (2006.01); A61K 48/00 (2006.01); A61K 31/7088 (2006.01); C07D 311/00 (2006.01); A61P 29/00 (2006.01); A61K 31/573 (2006.01); A61K 31/713 (2006.01); C07D 311/72 (2006.01); C12N 15/64 (2006.01);
U.S. Cl.
CPC ...
C07D 295/088 (2013.01); A61K 9/127 (2013.01); A61K 9/1272 (2013.01); A61K 31/573 (2013.01); A61K 31/7088 (2013.01); A61K 31/713 (2013.01); A61K 45/00 (2013.01); A61K 47/22 (2013.01); A61K 48/00 (2013.01); A61P 29/00 (2018.01); C07D 311/00 (2013.01); C07D 311/72 (2013.01); C12N 15/64 (2013.01);
Abstract

The present invention aims to provide a cationic lipid that can be used as a nucleic acid delivery carrier, a lipid membrane structure using a cationic lipid, a nucleic acid-introducing agent using a cationic lipid, and a method of achieving nucleic acid introduction by using a nucleic acid-introducing agent containing a cationic lipid. A lipid membrane structure containing a cationic lipid represented by the formula (1) wherein each symbol is as defined in the DESCRIPTION, is superior in the stability in blood and tumor accumulation property. A nucleic acid-introducing agent using the cationic lipid can achieve high nucleic acid delivery efficiency of nucleic acid to be delivered into the cytoplasm.


Find Patent Forward Citations

Loading…